Growth Equity Opportunities V LLC 13D and 13G filings for CTI BioPharma Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-22 4:06 pm Sale |
2022-07-11 | 13D | CTI BioPharma Corp. CTIC |
Growth Equity Opportunities V LLC | 0 0.000% |
-9,613,101 (Position Closed) |
Filing |
| 2022-06-17 5:10 pm Purchase |
2022-06-07 | 13D | CTI BioPharma Corp. CTIC |
Growth Equity Opportunities V LLC | 9,613,101 8.800% |
2,228,285 (+30.17%) |
Filing |